TY  - GEN
AU  - Nozu,Kandai
AU  - Iijima,Kazumoto
AU  - Kanda,Kyoko
AU  - Nakanishi,Koichi
AU  - Yoshikawa,Norishige
AU  - Satomura,Kenichi
AU  - Kaito,Hiroshi
AU  - Hashimura,Yuya
AU  - Ninchoji,Takeshi
AU  - Komatsu,Hiroshi
AU  - Kamei,Koichi
AU  - Miyashita,Ritsuko
AU  - Kugo,Masaaki
AU  - Ohashi,Hiroshi
AU  - Yamazaki,Hajime
AU  - Mabe,Hiroyo
AU  - Otsubo,Asa
AU  - Igarashi,Takashi
AU  - Matsuo,Masafumi
TI  - The pharmacological characteristics of molecular-based inherited salt-losing tubulopathies
SN  - 1945-7197
PY  - 2011///0114
KW  - Adolescent
KW  - Adult
KW  - Bartter Syndrome
KW  - drug therapy
KW  - Child
KW  - DNA Mutational Analysis
KW  - Diuretics
KW  - therapeutic use
KW  - Exons
KW  - genetics
KW  - Female
KW  - Frameshift Mutation
KW  - Furosemide
KW  - Gitelman Syndrome
KW  - Humans
KW  - Male
KW  - Mutation
KW  - Receptors, Drug
KW  - Sequence Deletion
KW  - Sodium-Potassium-Chloride Symporters
KW  - Solute Carrier Family 12, Member 1
KW  - Solute Carrier Family 12, Member 3
KW  - Symporters
KW  - Thiazides
KW  - Young Adult
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1210/jc.2010-0392
ER  -